Araz Mine, Çayır Derya
Dışkapı Yıldırım Beyazıt Training and Research Hospital, Clinic of Nuclear Medicine, Ankara, Turkey Phone: +90 532 666 73 13 E-mail:
Mol Imaging Radionucl Ther. 2017 Feb 5;26(1):1-8. doi: 10.4274/mirt.60783.
Positron emission tomography/computed tomography (PET/CT) with F-fluorodeoxyglucose (FDG) is used in staging, restaging, and evaluation of therapy response in many cancers as well as differentiated thyroid carcinomas especially in non-iodine avid variants. Its potential in less frequent thyroid tumors like medullary, anaplastic thyroid cancers, thyroid lymphoma and metastatic tumors of the thyroid however, is not well established yet. The aim of this review is to provide an overview on the recent applications and indications of F-FDG PET/CT in these tumors and to focus on the controversies in the clinical setting.
正电子发射断层扫描/计算机断层扫描(PET/CT)联合氟代脱氧葡萄糖(FDG)用于多种癌症以及分化型甲状腺癌(尤其是非碘摄取型变体)的分期、再分期及治疗反应评估。然而,其在髓样癌、未分化甲状腺癌、甲状腺淋巴瘤及甲状腺转移瘤等较少见甲状腺肿瘤中的应用潜力尚未明确。本综述旨在概述F-FDG PET/CT在这些肿瘤中的最新应用及适应证,并聚焦临床应用中的争议点。